Table 2.
Mean annual per-participant costs (in €) and self-reported effects (HADS) by group and assessment time (N = 1166)
| 12-Month Baseline | 12-Month Follow-Up | |||||||
|---|---|---|---|---|---|---|---|---|
| IG | CG | Differences | IG | CG | Differences | |||
| Mean (SD) | Mean (SD) | Mean [95%-CI] | p | Mean (SD) | Mean (SD) | Mean [95%-CI] | p | |
| Direct costs | 615 (1779) | 545 (1614) | 69.4 [−122, 272] | 0.49 | 637 (1201) | 456 (1318) | 181 [40, 318] | 0.01 |
| Out-patient care | 372 (669) | 342 (719) | 30.4 [−50, 110] | 0.45 | 431 (797) | 337 (708) | 94 [10, 180] | 0.03 |
| Rehabilitation | 45 (432) | 12 (200) | 33.7 [−2, 77] | 0.11 | 31 (320) | 0 (0) | 31 [8, 59] | 0.07 |
| Medication | 32 (100) | 35 (125) | −3.1 [−16, 10] | 0.63 | 27 (90) | 35 (128) | −9 [−21, 4] | 0.18 |
| In-patient care | 165 (1,43) | 157 (1246) | 8.4 [− 147, 168] | 0.91 | 55 (722) | 84 (964) | −28 [−131, 64] | 0.58 |
| Intervention costs | 93 (0) | 0 (0) | 93 [93, 93] | < .001 | ||||
| Indirect costs | 844 (3551) | 891 (4074) | −47.4 [− 494, 378] | 0.83 | 749 (3713) | 986 (4620) | −237 [−749, 236] | 0.34 |
| Total costs | 1458 (4523) | 1436 (4895) | 22.0 [−526, 541] | 0.9 | 1386 (4224) | 1443 (5280) | − 57 [− 634, 480] | 0.84 |
| Effects (HADS) | 15.4 (7.0) | 15.3 (7.2) | 0.05 [−0.76, 0.87] | 0.9 | 12.4 (6.8) | 14.4 (7.7) | −1.97 [−2.81, − 1.14] | < .001 |